Growth Hormone, Somatomedins, and Growth Failure
- 1 August 1978
- journal article
- research article
- Published by Taylor & Francis in Hospital Practice
- Vol. 13 (8) , 57-67
- https://doi.org/10.1080/21548331.1978.11707384
Abstract
Severe growth hormone deficiency may occur in as many as one in 4,000 children, short stature from less severe deficiency in even more. Replacement therapy is highly effective, but scarcity of HGH restricts treatment to the most severely affected. Since GH acts on skeletal tissues indirectly by stimulating production of the serum peptides called somatomedins, their synthesis may eventually lead to more widespread treatment.Keywords
This publication has 7 references indexed in Scilit:
- Prevalence of severe growth hormone deficiency.BMJ, 1977
- Aetiology of idiopathic growth hormone deficiency in England and Wales.Archives of Disease in Childhood, 1977
- Neurotransmitters as Regulators of Endocrine FunctionHospital Practice, 1975
- Relation Between Growth Hormone and SomatomedinAnnual Review of Medicine, 1975
- Acute and Long-Term Responsiveness to Growth Hormone in Children with Short StaturePediatric Research, 1972
- Effect of Human Growth Hormone Treatment for 1 to 7 Years on Growth of 100 Children, with Growth Hormone Deficiency, Low Birthweight, Inherited Smallness, Turner's Syndrome, and Other ComplaintsArchives of Disease in Childhood, 1971
- Sequences of Pituitary and Placental Lactogenic and Growth Hormones: Evolution from a Primordial Peptide by Gene ReduplicationProceedings of the National Academy of Sciences, 1971